16 results
DPP-4 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
DPP-4 Inhibitors ... - Pharmacology ... GLP-I receptor agonist ... #Inhibitors #Pharmacology ... diabetes #endocrinology
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
GLP-1 receptor agonists ... events TZDs DPP ... inhibitors - ↓ ... comparison #management #endocrinology ... #dm2
Oral Hypoglycemics in Diabetes Management
1  INSULIN SENSITIZER
 • TZD 
     -
- PPAR gamma agonist ... AGENTS • GLP-1 agonists ... (Adlyxin) • DPP ... by inhibiting DPP ... Diabetes #Management #pharmacology
DPP4 Inhibitors - Normal and Renal Dosing

Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
DPP4 Inhibitors ... inhibitors work ... #Dosing #Pharmacology ... Management #Diabetes #DM2 ... #Endocrinology
Mechanism of Action for Common Diabetes Medications

 • SGLT2i (Dapagliflozin)
 • TZD (Pioglitazone)
 • Biguanides (Metformin)
GLP-1 Receptor Agonists ... • DPP4i / Gliptins ... #Medications #pharmacology ... pathophysiology #endocrinology
Diabetes Combination Tablets - Estimated A1c Lowering 
Metformin + DPP4 
• Janumet (metformin + sitagliptin) 
•
Metformin + DPP4 ... dapagliflozin) Dpp4 ... Tablets #Oral #DM2 ... #Pharmacology # ... Pills #Endocrinology
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Sulfonylurea, TZD, DPP ... -4 inhibitor, GLP ... -1 receptor agonist ... #Medications #pharmacology ... comparison #table #endocrinology
GLP-1 Agonists

Adlyxin (Lixisenatide) Daily
Bydureon (Exenatide ER) Weekly 
Ozempic (Semaglutide) Weekly 
Trulicity (Dulaglutide) Weekly 
Victoza (Liraglutide) Daily
GLP-1 Agonists ... very similar to DPP4s ... #Pharmacology #Dosing ... #Diabetes #DM2 ... #Endocrinology
#diabetes #T2DM #antidiabeticagents #oraldiabeticagents

FIGURE 9.1 Glucose-lowering medication in type 2 diabetes: overall approach. For appropriate context,
outcomes trials; DPP ... dipeptidyl peptidase 4 inhibitor ... GLP-1 receptor agonist ... SGLT2i, SGLT2 inhibitor ... DOI: 10.2337/dci19
SGLT2 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
SGLT2 Inhibitors ... - Pharmacology ... #Pharmacology # ... Summary #DM2 #diabetes ... #endocrinology